CONMED Corporation (CNMD) — Analyst outlook / Analyst consensus target is. Based on 21 analyst ratings, the consensus is bullish — 7 Buy, 14 Hold.
The consensus price target is $78.00 (low: $61.00, high: $95.00), representing an upside of 97.8% from the current price $39.44.
Analysts estimate Earnings Per Share (EPS) of $4.03 and revenue of $1.30B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $4.29 vs est $4.03 (beat +6.5%). 2025: actual $1.52 vs est $4.50 (missed -66.2%). Analyst accuracy: 0%.
CNMD Stock — 12-Month Price Forecast
$78.00
▲ +97.77% Upside
Average Price Target
Based on 21 Wall Street analysts offering 12-month price targets for CONMED Corporation, the average price target is $78.00, with a high forecast of $95.00, and a low forecast of $61.00.
The average price target represents a +97.77% change from the last price of $39.44.
Highest Price Target
$95.00
Average Price Target
$78.00
Lowest Price Target
$61.00
CNMD Analyst Ratings
Hold
Based on 21 analysts giving stock ratings to CONMED Corporation in the past 3 months
EPS Estimates — CNMD
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $4.29
vs Est $4.03
▲ 6.1% off
2025
Actual $1.52
vs Est $4.50
▼ 196.1% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — CNMD
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.307B
vs Est $1.302B
▲ 0.4% off
2025
Actual $1.375B
vs Est $1.368B
▲ 0.5% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
